Skip to content
Search

Latest Stories

Strides Pharma consolidates European operations in Switzerland

Oren Weininger appointed as chairman of the board of Strides Pharma International AG
Image source: www.strides.com

Fairmed Healthcare’s Oren Weininger has been appointed as chairman of the board of Strides Pharma International AG

Indian pharmaceutical company Strides Pharma Science Limited has announced the consolidation of its European business through Strides Pharma International AG, based in Zug, Switzerland.

Headquartered in Bangalore, Strides Pharma is a leading manufacturer of active pharmaceutical ingredients (APIs) and diverse pharmaceutical products. Notably, it is among the world's largest manufacturers of Ibuprofen and Macrogol in various forms.


The company has a global manufacturing footprint with eight facilities spread across four continents and a strong presence in 100 countries.

Oren Weininger, the longstanding leader of Fairmed Healthcare, has been appointed as the CEO and Chairman of the Board of Strides Pharma International AG.

Highlighting the company’s strategic move, Weininger stated, "With this strengthened European B2B presence, we can respond faster to our customers' needs and provide flexible, innovative solutions, and interesting generic portfolio, including comprehensive support in supply chain and quality management and regulatory processes by Strides Pharma International and the EU GMP-site in Hamburg, Germany."

The company’s key markets in Europe include Central and Southern Europe (especially Germany), Scandinavia, Benelux, and the Visegrád countries.

Weininger comes with vast experience in the pharmaceutical industry, including roles at Dexcel Pharma and Kamedis before he became CEO of Fairmed Healthcare AG in 2014. He later acquired the company in 2018.

Strides Pharma, after a period of successful partnership with Fairmed Healthcare, invested in the company in 2019, further bolstering its leading product lines.

Alongside his role at Strides Pharma International AG, Weininger continues to lead Fairmed Healthcare GmbH in Hamburg.

Strides Pharma's partner-centric in-licensing portfolio of over 250 formulations is consolidated in synergICE as a one-stop shop. It includes generics, sterile injectables, value-added products, women's health hormones, lyophilized orally dissolving tablets and end-to-end biopharmaceutical CDMO services.

More For You

NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less